Search | IOVS | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Development of a thermosensitive hydrogel for sustained drug release and in situ bleb support

Richard Zhang; James J Armstrong; Cindy M L Hutnik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3435. doi:

ARVO Annual Meeting Abstract June 2021

Development of a Novel Bioartificial Surgical Outflow Tract Model for Rapid Screening of Anti-Fibrotics Adjuvants

Matthew Fung; James Jacob Armstrong; Hong Liu; Cindy M L Hutnik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3436. doi:

ARVO Annual Meeting Abstract June 2021

Treatment of ocular inflammation: effects of COX-2 acetylating immuno-resolvents (CAIRs) in THP-1-derived macrophages and a rat model of endotoxin-induced uveitis

Anastasiya Vinokurtseva; James Jacob Armstrong; Hong Liu; Patti Kiser; Cindy M L Hutnik

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3452. doi:

ARVO Annual Meeting Abstract June 2020

Development of an injectable, space-filling thermosensitive hydrogel as a subconjunctival bleb scaffold and sustained release drug depot

Jake Armstrong; Richard Zhang; Cindy M L Hutnik

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3150. doi:

ARVO Annual Meeting Abstract July 2018

Assessing the effects of indomethacin and dexamethasone on wound healing using a 3D bioartificial tissue of human Tenon’s capsule fibroblasts

Jim Denstedt; James Armstrong; Cindy ML Hutnik; Charles Trelford

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):479. doi:

ARVO Annual Meeting Abstract July 2018

Acetylsalicylic acid reduces collagen contraction, remodelling and myofibroblast proliferation in subconjunctival tissue mimetic

James Jacob Armstrong; James Denstedt; Cindy ML Hutnik

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2665. doi:

ARVO Annual Meeting Abstract July 2018

A Systematic Review and Meta-Analysis of Intravenous Sedation in Modern Cataract Surgery

Efstathia Kiatos; James Jacob Armstrong; Cindy ML Hutnik; Stephen Tsioros; Monali Malvankar; William Hodge

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4778. doi:

ARVO Annual Meeting Abstract June 2015

Visual Function in Patients with Amyotrophic Lateral Sclerosis

Russell Huang; Joseph Simonett; Nailah Siddique; Jennifer Armstrong; Lisa Kinsley; Teepu Siddique; Nicholas J Volpe; Amani A Fawzi

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):517. doi:

Clinical and Epidemiologic Research July 2013

Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)

PDF

Ronald P. Danis; Amitha Domalpally; Emily Y. Chew; Traci E. Clemons; Jane Armstrong; John Paul SanGiovanni; Frederick L. Ferris, III
TAGS: color, eye diseases, fundus photography, eye, drusen, diagnostic imaging
Invest. Ophthalmol. Vis. Sci.. 2013; 54(7):4548-4554. doi: https://doi.org/10.1167/iovs.13-11804

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2013

Ocular Manifestations and Optic Nerve Changes in Patients with Amyotrophic Lateral Sclerosis (ALS)

Joseph Simonett; Jonathan Chou; Nailah Siddique; Jennifer Armstrong; Amani Fawzi; Teepu Siddique; Nicholas Volpe

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):4382. doi:

ARVO Annual Meeting Abstract April 2010

Evaluation of Age-Related Macular Degeneration Associated Geographic Atrophy From Stereoscopic Color Fundus Photographs and Fundus Autofluorescence Images

C. N. Kruse; A. Domalpally; J. Armstrong; Q. Peng; B. Blodi; R. P. Danis, Jr.; Age-Related Eye Disease Study 2 (AREDS2) ResearchGroup

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):1640. doi:

ARVO Annual Meeting Abstract April 2010

Evaluation of Precursors of Geographic Atrophy Associated With Age-Related Macular Degeneneration in the Age-Related Eye Disease Study 2 (AREDS2)

J. R. Armstrong; J. White; A. Domalpally; R. P. Danis, Jr.; B. Blodi; Q. Peng; M. L. Klein; AREDS2 Research group

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):314. doi:

ARVO Annual Meeting Abstract April 2009

Reproducibility of Classification by AREDS Severity Scale and Component Features in AREDS2

R. P. Danis; J. Armstrong; Q. Peng; A. Domalpally; L. Hubbard; AREDS2

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):256. doi:

ARVO Annual Meeting Abstract April 2009

Y402H Variant in Complement Factor H (CFH): Association with Age-Related Maculopathy (ARM) and Correlation with Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Lutein & Zeaxanthin (L&Z) in a Mid-South US Elderly Sample

A. Iannaccone; K. Spencer; L. M. Olson; J. T. Armstrong; K. C. Johnson; E. Kenyon; S. Satterfield; E. J. Johnson; S. B. Kritchevsky; J. L. Haines

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):961. doi:

ARVO Annual Meeting Abstract April 2009

Changes From Baseline to One Year in Fundus Autofluorescence (FAF) Images in the Age-Related Eye Disease Study 2 (AREDS2)

J. R. Armstrong; A. Domalpally; R. P. Danis, Jr.; B. Blodi; Q. Peng; L. Hubbard; AREDS2 Research Group

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):718. doi:

ARVO Annual Meeting Abstract May 2008

Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2

J. R. Armstrong; M. Webster; A. Domalpally; R. Danis, Jr.; B. Blodi; B. Zhang; M. Fleischli; H. Larry; Age-Related Eye Diseases Study 2 Research Group

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2234. doi:

ARVO Annual Meeting Abstract May 2008

A Pilot Study on the Effect of Lutein and Zeaxanthin Supplementation on Psychophysical and Electrophysiological Macular Outcome Measures

J. T. Armstrong; A. M. Deaton-Cantrell; A. Iannaccone

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4964. doi:

ARVO Annual Meeting Abstract May 2008

Macular Pigment Optical Density, C-Reactive Protein, and Serum Lutein and Zeaxanthin in the Elderly

A. Iannaccone; E. J. Johnson; J. T. Armstrong; E. Kenyon; T. Harris; S. Satterfield; K. C. Johnson; S. B. Kritchevsky

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):4965. doi:

ARVO Annual Meeting Abstract May 2007

Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Serum Lutein and Zeaxanthin (L&Z) in Age-Related Maculopathy (ARM)

A. Iannaccone; E. J. Johnson; K. T. Gallaher; J. Armstrong; E. Kenyon; T. Harris; K.-J. Yeum; S. Satterfield; K. C. Johnson; S. B. Kritchevsky

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2147. doi:

ARVO Annual Meeting Abstract May 2007

Geographic Atrophy Evaluated From Digital Images: An Extension of the AREDS Classification of AMD

J. R. Armstrong; C. Fink; T. Harding; C. Hurtenbach; B. Zhang; M. Fleischli; R. P. Danis, Jr.; L. D. Hubbard

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):2174. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Development of a thermosensitive hydrogel for sustained drug release and in situ bleb support

Development of a Novel Bioartificial Surgical Outflow Tract Model for Rapid Screening of Anti-Fibrotics Adjuvants

Treatment of ocular inflammation: effects of COX-2 acetylating immuno-resolvents (CAIRs) in THP-1-derived macrophages and a rat model of endotoxin-induced uveitis

Development of an injectable, space-filling thermosensitive hydrogel as a subconjunctival bleb scaffold and sustained release drug depot

Assessing the effects of indomethacin and dexamethasone on wound healing using a 3D bioartificial tissue of human Tenon’s capsule fibroblasts

Acetylsalicylic acid reduces collagen contraction, remodelling and myofibroblast proliferation in subconjunctival tissue mimetic

A Systematic Review and Meta-Analysis of Intravenous Sedation in Modern Cataract Surgery

Visual Function in Patients with Amyotrophic Lateral Sclerosis

Methods and Reproducibility of Grading Optimized Digital Color Fundus Photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2)

Ocular Manifestations and Optic Nerve Changes in Patients with Amyotrophic Lateral Sclerosis (ALS)

Evaluation of Age-Related Macular Degeneration Associated Geographic Atrophy From Stereoscopic Color Fundus Photographs and Fundus Autofluorescence Images

Evaluation of Precursors of Geographic Atrophy Associated With Age-Related Macular Degeneneration in the Age-Related Eye Disease Study 2 (AREDS2)

Reproducibility of Classification by AREDS Severity Scale and Component Features in AREDS2

Y402H Variant in Complement Factor H (CFH): Association with Age-Related Maculopathy (ARM) and Correlation with Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Lutein & Zeaxanthin (L&Z) in a Mid-South US Elderly Sample

Changes From Baseline to One Year in Fundus Autofluorescence (FAF) Images in the Age-Related Eye Disease Study 2 (AREDS2)

Comparison of Fundus Autofluorescence Images to Digital Color Images for RPE Atrophy in AREDS2

A Pilot Study on the Effect of Lutein and Zeaxanthin Supplementation on Psychophysical and Electrophysiological Macular Outcome Measures

Macular Pigment Optical Density, C-Reactive Protein, and Serum Lutein and Zeaxanthin in the Elderly

Macular Pigment Optical Density (MPOD), Serum C-Reactive Protein (CRP), and Serum Lutein and Zeaxanthin (L&Z) in Age-Related Maculopathy (ARM)

Geographic Atrophy Evaluated From Digital Images: An Extension of the AREDS Classification of AMD

To View More...

You must be signed into an individual account to use this feature.